Welcome to Spate Radio hosted by Antoine Maurice King , ranked by Google as one of the top podcasts in the world! Join us as we dive deep into the latest in hip hop news, music business insights, and exclusive celebrity interviews. Whether you’re an independent artist, a music industry professional, or a fan of hip hop culture, Spate Radio brings you unfiltered conversations with the most influential voices shaping the scene today. In each episode, we break down the trends driving the music ...
…
continue reading
コンテンツは Dean M. Calhoun, CIH, Affygility Solutions, and LLC によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Dean M. Calhoun, CIH, Affygility Solutions, and LLC またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Player FM -ポッドキャストアプリ
Player FMアプリでオフラインにしPlayer FMう!
Player FMアプリでオフラインにしPlayer FMう!
Biopharma EHS Podcast Episode No. 17
Manage episode 156330781 series 1185076
コンテンツは Dean M. Calhoun, CIH, Affygility Solutions, and LLC によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Dean M. Calhoun, CIH, Affygility Solutions, and LLC またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Containment Validation and Surrogate Monitoring
In this episode of the Biopharma EHS podcast, Dean M. Calhoun, CIH, President and CEO of Affygility Solutions discusses the following topics:
- A review of Episode no. 16 of the Biopharma EHS podcast. In that episode, Dean M. Calhoun, President and CEO of Affygility Solutions, and Dr. Joe Nieusma, Sr. Occupational Toxicologist with Affygility Solutions discuss Category 4 and 5 potent compounds. Our discussions include what factors determine a Category 4 or 5 potent compound, why the occupational exposure limit (OEL) alone is not enough to determine if a specific compound falls into a category 4 or 5 control band, and specific examples of potent compounds that are classified into these control bands.
- An interview with Matt Meiners, Division Manager, Laboratory Services for the Bureau Veritas, Lake Zurich, Industrial Hygiene Laboratory. In this interview, Dean and Matt discuss containment validation and surrogate monitoring. Often call SMEPAC testing. Matt provides insight into why containment validation is necessary, the advantages and disadvantages of different surrogate compounds, the sensitivity of their industrial hygiene laboratory methods for surrogate compounds, the advantages and disadvantages of the total dust versus the Institute of Occupational Medicine (IOM) method of sampling.
- Upcoming events and happenings of interest to environmental, health and safety professionals in the biotechnology, pharmaceutical, and medical device industries. These events include:
- Affygility Solutions' webinars. These webinars include:
- Advance Topics in Potent Compound Safety
- Dermal Exposure and Absorption of Active Pharmaceutical Ingredients
- Isoflurane Safety
- Society of Toxicology Annual Meeting in San Francisco, CA
- Society of Chemical Hazard Communication Spring Meeting in Nashville, TN
- The above webinars are a great way for environmental, health and safety professionals to obtain certification maintenance points.
If you have questions regarding this podcast, please email podcast @ affygility.com
29 つのエピソード
Manage episode 156330781 series 1185076
コンテンツは Dean M. Calhoun, CIH, Affygility Solutions, and LLC によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Dean M. Calhoun, CIH, Affygility Solutions, and LLC またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Containment Validation and Surrogate Monitoring
In this episode of the Biopharma EHS podcast, Dean M. Calhoun, CIH, President and CEO of Affygility Solutions discusses the following topics:
- A review of Episode no. 16 of the Biopharma EHS podcast. In that episode, Dean M. Calhoun, President and CEO of Affygility Solutions, and Dr. Joe Nieusma, Sr. Occupational Toxicologist with Affygility Solutions discuss Category 4 and 5 potent compounds. Our discussions include what factors determine a Category 4 or 5 potent compound, why the occupational exposure limit (OEL) alone is not enough to determine if a specific compound falls into a category 4 or 5 control band, and specific examples of potent compounds that are classified into these control bands.
- An interview with Matt Meiners, Division Manager, Laboratory Services for the Bureau Veritas, Lake Zurich, Industrial Hygiene Laboratory. In this interview, Dean and Matt discuss containment validation and surrogate monitoring. Often call SMEPAC testing. Matt provides insight into why containment validation is necessary, the advantages and disadvantages of different surrogate compounds, the sensitivity of their industrial hygiene laboratory methods for surrogate compounds, the advantages and disadvantages of the total dust versus the Institute of Occupational Medicine (IOM) method of sampling.
- Upcoming events and happenings of interest to environmental, health and safety professionals in the biotechnology, pharmaceutical, and medical device industries. These events include:
- Affygility Solutions' webinars. These webinars include:
- Advance Topics in Potent Compound Safety
- Dermal Exposure and Absorption of Active Pharmaceutical Ingredients
- Isoflurane Safety
- Society of Toxicology Annual Meeting in San Francisco, CA
- Society of Chemical Hazard Communication Spring Meeting in Nashville, TN
- The above webinars are a great way for environmental, health and safety professionals to obtain certification maintenance points.
If you have questions regarding this podcast, please email podcast @ affygility.com
29 つのエピソード
Alle episoder
×プレーヤーFMへようこそ!
Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。